Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Events » NECA attends Professionals Uplifting Patient Partnership (PUPP)’s final event of the year

NECA attends Professionals Uplifting Patient Partnership (PUPP)’s final event of the year

  • December 5, 2025

NECA was pleased to attend “Unfiltered: Personal Reflections on HTA and Consumer Engagement” with Jo Watson on Thursday 4 December. The event brought together patient organisations, industry colleagues and consumer advocates for an open conversation about the shifting Health Technology Assessment (HTA) environment.

Jo reflected on a year marked by system change, departmental pressures and evolving committee structures, noting the growing complexity for patient groups and the importance of staying aligned on shared priorities and collaboration.

Consumer input was a central theme, with Jo emphasising how deeply patient perspectives are now embedded across HTA processes. Attendees also explored practical challenges around transparency, feedback pathways and how smaller organisations can participate effectively with limited resources.

Broader system pressures, including government efficiency measures and their potential impact on assessment timelines, were also discussed. The group reflected on the need for policy settings that continue to support timely and equitable access to medicines and diagnostics within Australia’s national medicines framework.

NECA welcomed the chance to join this valuable end-of-year discussion and thanks the organisers for fostering such constructive dialogue at a pivotal time for HTA and health reform.

Share this post

Recent posts

AUS-NET Update, January 2026

January 20, 2026

CommNETs 2025

December 15, 2025

NECA attends Professionals Uplifting Patient Partnership (PUPP)’s final event of the year

December 5, 2025

Navigating Extrapulmonary Neuroendocrine Carcinoma: COR2ED Resource Featuring Insights from NECA CEO Meredith Cummins

December 5, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousNavigating Extrapulmonary Neuroendocrine Carcinoma: COR2ED Resource Featuring Insights from NECA CEO Meredith Cummins
NextCommNETs 2025Next

Related Posts

AUS-NET Update, January 2026

The AUS-NET trial commenced in 2022 and is running through to 2027. Across the five Centres of Excellence—The Queen Elizabeth Hospital, Royal North Shore Hospital,

CommNETs 2025

The 2025 CommNETs Annual Meeting was held in Vancouver on 5–6 December, bringing together neuroendocrine cancer specialists from across Commonwealth countries. CommNETs (Commonwealth Neuroendocrine Tumour

Navigating Extrapulmonary Neuroendocrine Carcinoma: COR2ED Resource Featuring Insights from NECA CEO Meredith Cummins

Nuclear Medicine Round Table

On Monday 17 November NECA attended the National Roundtable – Sustainable Pathways: Shaping the Future of Nuclear Medicines in Australia at Parliament House. Nuclear Medicine

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2026 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin